Global Cell-free DNA testing market

Mayurikathade08 Oct, 2020Business

Global Cell-free DNA testing market was valued US$ 104.69 Mn in 2018 and is expected to reach US$ XX Mn by 2026, at a CAGR of XX % during a forecast period. Global Cell-free DNA testing market Cell-free DNA (cfDNA) is also called Noninvasive prenatal testing (NIPT). The non-invasive prenatal test is a new technology being used to assess the risk of a pregnant woman's and taking a sample of blood from the vein rather than inserting a needle into the uterus similar to amniocentesis. The cell-free DNA testing is used in many fields such as gynecology, oncology, and transplantation to identify mutations in cancer patients. Cell-free DNA testing identify various chromosomal abnormalities in the fetus, to know the gender of the fetus. Increasing healthcare expenditure and awareness are the key factors driving the cell-free DNA testing market.